DISCOVER MORE
Our Corporate Access Portal serves as a tool to inform and engage investors by providing in-depth investor profiles for selected public companies and aims to facilitate meaningful one-on-one meetings between investors and company executives.
Investors can unlock captivating fireside chats and company webcasts; discover insightful KOL panels with public company executives and industry experts; and stay informed with real-time stock data, SEC filings, press releases and more.
Explore our Featured Companies and schedule your one-on-one meetings today!
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are shaping adoption, and where investors may find compelling opportunities across the healthcare IT landscape.
RECENT NEWS
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
CARMEL, Ind., March 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology...
Orion Digital Reports Q4 and Full-Year 2025 Results; Wealth Revenue Grows 36% as Subscription & Services Reach 62% of Revenue
Wealth AUM of $498M, up 17% Year-over-year European Payments Volume of $11.1B, up 14% Year-over-year FY 2025 Adjusted EBITDA1 of $7.1M Strong...
ARIANNE PHOSPHATE EXTENDS ITS CREDIT FACILITIES
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQB (USA)SAGUENAY, QC, March 12, 2026 /CNW/ - Arianne Phosphate (the "Company" or "Arianne")...
RECENT EVENTS
Aytu BioPharma (AYTU) Fireside Chat
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system...
Cadrenal Therapeutics (CVKD) Fireside Chat
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is developing differentiated products designed to bridge critical gaps in current acute and chronic...
Alpha Tau (DRTS) Fireside Chat
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into...
